Lasa Supergenerics Ltd.
| BSE: 540702 | Sector: Health care |
| NSE: LASA | ISIN Code: INE670X01014 |
| BSE 12:06 | 19 Aug | 35.35 |
-0.55 (-1.53%) |
OPEN
36.85 |
HIGH
37.30 |
LOW
35.20 |
| NSE 11:54 | 19 Aug | 35.55 |
-0.15 (-0.42%) |
OPEN
36.35 |
HIGH
36.90 |
LOW
35.00 |
| OPEN | 36.85 |
| PREVIOUS CLOSE | 35.90 |
| VOLUME | 18827 |
| 52-Week high | 85.05 |
| 52-Week low | 25.40 |
| P/E | |
| Mkt Cap.(Rs cr) | 144 |
| Buy Price | 35.40 |
| Buy Qty | 500.00 |
| Sell Price | 35.90 |
| Sell Qty | 44.00 |
- Financial Overview
- Balance Sheet
- Profit & Loss
- Cash Flow
- Ratios
- Quarterly
- Half Yearly
- Nine Monthly
- Yearly
Filter:
Lasa Supergenerics Ltd. (LASA) - Half Yearly Result
Particulars ( cr) |
Mar '22 | Sep '21 | Mar '21 | Sep '20 | Mar '20 |
| Net Sales/Income From Operations | 66.95 | 70.18 | 93.09 | 109.29 | 87.88 |
| Other Income | 0.02 | 0.04 | 0.02 | 0.04 | 0.10 |
| Total Income | 66.97 | 70.21 | 93.11 | 109.33 | 87.97 |
| Total Expenditure | 53.16 | 76.20 | 70.84 | 84.31 | 70.47 |
| Operating Profit | 13.82 | -5.99 | 22.26 | 25.01 | 17.51 |
| Interest | 0.01 | 0.03 | 0.51 | 1.45 | 3.98 |
| Gross Profit | 13.80 | -6.01 | 21.75 | 23.57 | 13.53 |
| Depreciation | 7.07 | 6.93 | 8.03 | 7.79 | 8.75 |
| PBT | 6.73 | -12.94 | 13.71 | 15.77 | 4.79 |
| Tax | 0.20 | 0.42 | 1.97 | -0.91 | 1.28 |
| Net Profit/(Loss) | 7.57 | -12.94 | 10.35 | 12.42 | 5.16 |
| Minority Interest After NP | - | - | - | - | - |
| Net Profit after Minority Interest | - | - | - | - | - |
| Exceptional Items | 4.04 | -11.52 | 0.00 | 0.00 | 0.00 |
| Profit After Exceptional Items | 3.53 | -1.42 | 10.35 | 12.42 | 5.16 |
| Equity Share Capital | 40.67 | 40.67 | 40.67 | 40.67 | 40.67 |
| Reserves Excluding Revaluation Reserves | 0.00 | 0.00 | 0.00 | 113.22 | 0.00 |
| EPS | |||||
| Basic EPS | 1.86 | -3.18 | 2.55 | 3.05 | 1.27 |
| Public Share Holding | |||||
| No Of Shares (Crores) | 0 | 0 | 0 | 0 | 0 |
| Share Holding (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Promoters and Promoter Group Shareholding | |||||
| a) Pledged/Encumbered | |||||
| - Number of Shares (Crores) | 0 | 0 | 0 | 0 | 0 |
| - Per. of Shares (as a % of the total sh. of prom. and promoter group) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| - Per. of Shares (as a % of the total Share Cap. of the company) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| b) Non-encumbered | |||||
| - Number of Shares (Crores) | 0 | 0 | 0 | 0 | 0 |
| - Per. of shares (as a % of the total sh. of prom. and promoter group) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| - Per. of shares (as a % of the total Share Cap. of the company) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Note : | PBT include deferred tax and fringe benefit tax Net profit figures include extra-ordinary items income/expenditure. | ||||
Quick Links for Lasa Supergenerics:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
